-
7 Articoli
-
7 Foto
-
0 Video
-
17/05/1984
-
Seguito da 1 people
Cerca
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian
Portuguese (Brazil)
Aggiornamenti recenti
-
sirna function Nuovo$110In stock0 AnteprimasiRNA, as the most used RNAi tool to induce short-term gene silencing in mammals, now is showing a big therapy potential. https://rna.bocsci.com/support/sirna-applications.html
siRNA, as the most used RNAi tool to induce short-term gene silencing in mammals, now is showing a big therapy potential. https://rna.bocsci.com/support/sirna-applications.html0 Commenti 0 condivisioni 1K Views 0 Anteprima -
siRNA Phosphate backbone modification Nuovo$110In stock0 AnteprimasiRNA is one of the valued tools which is widely used to investigate the functions of genes and gene silencing. https://rna.bocsci.com/products-services/chemically-modified-sirna.html
siRNA is one of the valued tools which is widely used to investigate the functions of genes and gene silencing. https://rna.bocsci.com/products-services/chemically-modified-sirna.html0 Commenti 0 condivisioni 1K Views 0 Anteprima -
AT 1 Nuovo$110In stock0 AnteprimaAT 1 is a highly selective BRD4 protein degrader composed of a BET bromodomain inhibitor (+)-JQ1 conjugated to a von Hippel-Lindau (VHL) ligand. https://ptc.bocsci.com/product/at-1-cas-2098836-45-2-169850.html
AT 1 is a highly selective BRD4 protein degrader composed of a BET bromodomain inhibitor (+)-JQ1 conjugated to a von Hippel-Lindau (VHL) ligand. https://ptc.bocsci.com/product/at-1-cas-2098836-45-2-169850.html0 Commenti 0 condivisioni 1K Views 0 Anteprima -
PROTAC NMR Nuovo$110In stock0 AnteprimaAs a leading service provider in drug discovery and research, BOC Sciences is fully capable and committed to providing one-stop proteolysis targeting molecular drug discovery based on chimeric (PROTAC®). https://ptc.bocsci.com/services/nmr.html
As a leading service provider in drug discovery and research, BOC Sciences is fully capable and committed to providing one-stop proteolysis targeting molecular drug discovery based on chimeric (PROTAC®). https://ptc.bocsci.com/services/nmr.html0 Commenti 0 condivisioni 1K Views 0 Anteprima -
ARV-825 Nuovo$110In stock0 AnteprimaARV-825 is a BRD4 inhibitor based on PROTAC technology. ARV-825 recruits BRD4 to E3 ubiquitin ligase cereblon, resulting in the degradation of BRD4. https://ptc.bocsci.com/product/arv-825-cas-1818885-28-7-474664.html
ARV-825 is a BRD4 inhibitor based on PROTAC technology. ARV-825 recruits BRD4 to E3 ubiquitin ligase cereblon, resulting in the degradation of BRD4. https://ptc.bocsci.com/product/arv-825-cas-1818885-28-7-474664.html0 Commenti 0 condivisioni 1K Views 0 Anteprima -
SNIPER Nuovo$110In stock0 AnteprimaAmong the natural protein degradation cascades, the ubiquitin-proteasome (UP) cascade is most characteristic. https://ptc.bocsci.com/products/sniper-3053.html
Among the natural protein degradation cascades, the ubiquitin-proteasome (UP) cascade is most characteristic. https://ptc.bocsci.com/products/sniper-3053.html0 Commenti 0 condivisioni 1K Views 0 Anteprima -
mPEG CLS Nuovo$110In stock0 AnteprimamPEG-Cholesterol (mPEG-CLS) is a unilaterally active PEG derivative. It is a lipophilic liposome with good water solubility. https://peg.bocsci.com/catcs/685/mpeg-cls/
mPEG-Cholesterol (mPEG-CLS) is a unilaterally active PEG derivative. It is a lipophilic liposome with good water solubility. https://peg.bocsci.com/catcs/685/mpeg-cls/0 Commenti 0 condivisioni 1K Views 0 Anteprima
Altre storie